tak 044 has been researched along with Endotoxemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaha, K; Hirata, Y; Mitaka, C; Nagura, T; Tsunoda, Y; Yokoyama, K | 1 |
| Gandhi, CR; Kuddus, RH; Murase, N; Nemoto, EM | 1 |
2 other study(ies) available for tak 044 and Endotoxemia
| Article | Year |
|---|---|
Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist.
Topics: Acute Kidney Injury; Animals; Blood Gas Analysis; Critical Care; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Endotoxemia; Hemodynamics; Lipopolysaccharides; Male; Peptides, Cyclic; Prospective Studies; Renal Circulation | 1999 |
Endotoxin treatment causes an upregulation of the endothelin system in the liver: amelioration of increased portal resistance by endothelin receptor antagonism.
Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Endotoxemia; Endotoxins; Liver; Male; Nitric Oxide; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; RNA, Messenger; Up-Regulation | 2001 |